The auspicious dragon bid farewell to the new year, and the spirit snake came to sing. On the occasion of the Chinese New Year in 2025, the board of directors of Fujian Amount Biotechnology Co., Ltd. is filled with gratitude and extends the sincerest respect and best wishes to all levels of leaders, friends, partners, and diligent employees who have long cared for and supported the development of Amount Biotechnology!
Standing at the beginning of the year, looking towards the road ahead, diligently practicing the abundant fruits of the year.
Looking back on the past, we set sail and explore the unknown in the vast sea of biotechnology. In the fields of concentrated preparation of bioactive substances and high-sensitivity diagnostics, we have successfully sailed towards the shore of innovation with technology as the propeller and innovation as the sail. We rely on the gentle and efficient innovative technology engine of "Xiaoba", which not only greatly improves the extraction efficiency and quality of bioactive substances, but also paves a new and broader path for accurate diagnosis of diseases and research and development of new drugs. This technology is not only a revolutionary breakthrough in traditional methods, but also a contribution to medical progress and human health.
This year, we have been forging ahead on the road of platform construction, with frequent good news.
We have successively completed the recognition of Quanzhou's new research and development institutions and the introduction of the seventh batch of high-level talent teams in Quanzhou, and successfully passed the strict review and defense of the "Hundred Talents Plan" by the Fujian Provincial Department of Industry and Information Technology, entering the on-site inspection stage. We have established industry university research cooperation with the Chinese Academy of Sciences, Fujian Medical University, Huaqiao University School of Medicine, Quanzhou Normal University, the Second Affiliated Hospital of Fujian Medical University, the First Hospital of Quanzhou City, the Hyperuricemia and Gout Management Center, BGI and other scientific research institutions and colleges and universities, constantly improving our scientific research strength, and contributing our wisdom and strength to the progress and prosperity of the industry.
This year, we have achieved great success in the realm of intellectual property and reaped abundant rewards.
We use patents as a shield to safeguard the fruits of innovation. Invention patents in the UK, Japan, and EU regions have been granted successively, while the US region has entered the defense stage. One new invention patent and ten utility model patents have also been granted domestically, and multiple innovative achievements are currently applying for patent protection. These patent achievements not only demonstrate our leading position in technology research and development, but also provide solid guarantees and support for the company's commercialization process.
This year, we have been moving forward courageously and forcefully on the journey of market expansion.
We have successfully opened up domestic and international markets with our strong research and development capabilities and high-quality products. At present, various products such as the Small and Medium Sized Polymer Rapid Concentration Kit, Industrial Grade Small and Medium Sized Polymer Rapid Concentration System, and Concentrated Household Packaging have successfully entered the marketization stage and received good market feedback. The product line covers the laboratory application market, industrial application market, and household testing market.
Amidst the tumultuous waves, the tide rises without any obstacles.
Looking ahead to the future, Amount Biotechnology will continue to uphold the core concept of "technology for good, achieving extraordinary results", deepen technology research and development, optimize product structure, and improve service quality. We will embrace the wave of change with a more open attitude and light up the future path of biotechnology with the light of technology.
Here, we sincerely wish all leaders, friends from all walks of life, partners, and all employees good health, successful careers, and happy families. Let's work together and write a more brilliant tomorrow for Amount Biology!
Fujian Amount Biotechnology Co., Ltd
board of directors
January 1st, 2025